BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2013
View Archived Issues
Role for cannabinoid CB2 receptor signaling in Huntington's disease
Read More
MCT 1 linked to 3-bromopyruvate uptake and sensitivity in cancer cells
Read More
U.S. researchers present new vitamin D receptor ligands
Read More
Bristol-Myers Squibb prepares novel PDE10A inhibitors
Read More
University of Florida patents new interferon mimetic peptides
Read More
Alnylam Pharmaceuticals divulges new siRNAs
Read More
Nihon Medi-Physics presents new Alzheimer's disease diagnostics
Read More
New alpha7 nAChR positive allosteric modulators synthesized by Dainippon Sumitomo Pharma
Read More
Acorda Therapeutics reviews pipeline
Read More
Bristol-Myers Squibb studies BMS-986020 for IPF in phase II trial
Read More
Dainippon Sumitomo Pharma seeks Japanese approval for Meropen dosage
Read More
Amunix enters into licensing agreement with Janssen Biotech
Read More
FDA issues complete response letter for Rytary NDA
Read More
Novartis receives positive CHMP opinion for Ilaris in acute gouty arthritis
Read More
Results from a semiqualitative validation of [18F]-NAV-4694 imaging
Read More
Eisai begins recruiting patients in phase II study of Alzheimer's disease treatment candidate
Read More
Tresiba and Ryzodeg approved for diabetes in Europe
Read More
Array BioPharma presents update on ongoing projects
Read More
CSL Behring enrolls first patient in global phase III pediatric study of rIX-FP
Read More
Global phase I study of AZD-1208 commences
Read More
Translation research centers establish drug discovery and development alliance
Read More
BioCad advances development of Extimia for neutropenia
Read More
Second milestone achieved in Genfit's metabolic disorder collaboration with Sanofi
Read More